Joellen M. Schildkraut

ORCID: 0000-0002-0990-9339 · 31 papers in corpus · active 2004-2025

Study types

  • other 14
  • article 12
  • meta-analysis 2
  • preprint 2
  • journal-article 1

Condition tags

  • endometriosis 31
  • dysmenorrhea 1
journal-article 2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies
The Lancet. Oncology ·doi:10.1016/s1470-2045(11)70404-1
other 2012
Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1097/IGC.0b013e318231f140

BACKGROUND: Inactivating somatic mutations in the ARID1A gene are described in a significant fraction of clear cell and endometrioid ovarian cancers leading to loss of the corresponding protein (BAF250a). Expression of BAF250a was examined …

other 2011
Family and personal medical history and risk of meningioma
Journal of neurosurgery ·doi:10.3171/2011.6.JNS11129

OBJECT: Little is known about the epidemiology of meningioma, the most frequently reported primary brain tumor in the US. The authors undertook a case-control study to examine the relationship between family and personal medical history and…

other 2011
Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort
Fertility and sterility ·doi:10.1016/j.fertnstert.2010.06.059

OBJECTIVE: To investigate the association between self-reported endometriosis and the putative functional promoter +331C/T single nucleotide polymorphism and the PROGINS allele. DESIGN: Control subjects from ovarian cancer case-control stu…

article 2004
Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis
American Journal of Obstetrics and Gynecology ·doi:10.1016/j.ajog.2004.03.035
other 2004
Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology ·doi:10.1158/1055-9965.2141.13.12

OBJECTIVE: The progestagenic milieu of pregnancy and oral contraceptive use is protective against epithelial ovarian cancer. A functional single nucleotide polymorphism in the promoter of the progesterone receptor (+331A) alters the relativ…